Yellow fever was the first human disease to have a licensed vaccine and has long been considered important to understanding how epidemics break out and should be combated. It was introduced to the ...

The results reported that based on the model estimates, the WHO’s Eliminate Yellow Fever Epidemics (EYE) strategy, which aims for 50%, 60%, and 80% coverage across individuals between the ages ...

With cryo-EM, researchers can see every molecule in the virus, enabling the team to capture every angle and reconstruct it into a 3D structure featuring the details of the surface proteins.

Centuries after the disease was first reported in the Americas, an international team of researchers will embark on a groundbreaking study to develop models that predict epidemics of yellow fever ...

The standard yellow fever vaccine, known as YF17D, has been in use for 80 years and has a good safety record. It delivers a live, “attenuated” (weakened) strain of the yellow fever virus.

"Yellow fever vaccination: How strong immune responses are triggered." ScienceDaily. ScienceDaily, 15 May 2025. <www.sciencedaily.com / releases / 2025 / 05 / 250514180910.htm>.

In phase 1a of this clinical trial, we assessed the safety, side-effect profile, and pharmacokinetics of TY014, a fully human IgG1 anti–yellow fever virus monoclonal antibody. In a double-blind ...